Copyright
©The Author(s) 2024.
World J Gastrointest Endosc. Dec 16, 2024; 16(12): 661-667
Published online Dec 16, 2024. doi: 10.4253/wjge.v16.i12.661
Published online Dec 16, 2024. doi: 10.4253/wjge.v16.i12.661
Table 2 Indication for patency, n (%)
| Overall group, n = 135 | Extended patency group, n = 69 | P value | |
| Previous surgery | 43 (31.9) | 24 (34.8) | 0.7686 |
| Crohn’s disease | 32 (23.7) | 15 (21.7) | 0.8651 |
| Radiology | 18(13.3) | 10 (14.5) | 0.8344 |
| NSAIDs | 18 (13.3) | 8 (11.6) | 0.8286 |
| Endoscopic findings | 9 (6.7) | 5 (7.2) | - |
| Obstructive symptoms | 9 (6.7) | 4 (5.8) | - |
| Prior abdominal radiation | 3 (2.2) | 1 (1.4) | - |
| No clear indication | 3 (2.2) | 2 (2.9) | - |
- Citation: O'Hara FJ, Costigan C, McNamara D. Extended 72-hour patency capsule protocol improves functional patency rates in high-risk patients undergoing capsule endoscopy. World J Gastrointest Endosc 2024; 16(12): 661-667
- URL: https://www.wjgnet.com/1948-5190/full/v16/i12/661.htm
- DOI: https://dx.doi.org/10.4253/wjge.v16.i12.661